Exergame-Based Upper-Limb Rehabilitation in Adults With Chronic Stroke (NCT07423091) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Exergame-Based Upper-Limb Rehabilitation in Adults With Chronic Stroke
32 participantsStarted 2026-04
Plain-language summary
This study is a randomized controlled trial designed to evaluate the effectiveness of a semi-autonomous upper-limb rehabilitation program based on exergames in adults with chronic stroke. Participants will be randomly assigned (1:1) to either an exergame-based intervention or an individually delivered conventional home-based therapy program. The primary outcome is upper-limb functionality as measured by the Action Research Arm Test (ARAT). Secondary outcomes include upper-limb motor function and quality of life. The study also examines adherence, usability, and the feasibility of remote monitoring for long-term implementation.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18 years or older.
* Confirmed diagnosis of chronic stroke with more than 6 months of evolution.
* Ability to maintain independent sitting and standing (with or without assistive devices).
* Upper-limb functional capacity ranging from limited to moderate, defined as an ARAT score between 11 and 54 points.
* Ability to understand and follow simple instructions (Mini-Mental State Examination ≥ 23).
* Ability to provide informed consent personally or through a legal representative.
Exclusion Criteria:
* Acute illness, musculoskeletal pathology, or pain that interferes with the performance of rehabilitation exercises.
* Uncompensated sensory deficits, including significant visual or hearing impairments.
* Disruptive behavior or neuropsychiatric conditions that may limit participation.
* Active epilepsy or any medical contraindication to physical exercise.
* Botulinum toxin treatment affecting the upper limb within the previous 6 months.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Upper-Limb Functionality (Action Research Arm Test, ARAT)